This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q66031472
rdf:type
wikibase:Item
schema:description
клінічне випробування ensayu clínicu կլինիկական փորձարկում clinical trial klinisch onderzoek
rdfs:label
Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
skos:prefLabel
Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
schema:name
Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
p:P1476
wds:Q66031472-78464518-B390-4375-88A0-BEF34391893F
wdt:P1476
Phase II Study of Oxaliplatin, Continuous 5-Fluorouracil and External Beam Radiation Followed by Gemcitabine in Patients With Locally Advanced Pancreatic Cancer
p:P582
wds:Q66031472-9E0E465B-9EDD-470A-B36A-7BB3DC62759E
wdt:P582
2007-04-01T00:00:00Z
p:P31
wds:Q66031472-F3CFD706-8BB7-40F4-8ACE-456380CEE96E
wdt:P31
wd:Q30612
p:P580
wds:Q66031472-1DADC425-41E2-421F-A82E-8F2C5EEF8F26
wdt:P580
2004-12-01T00:00:00Z
p:P17
wds:Q66031472-BE4E99EB-0175-42D8-B6B7-0C19E155880D
wdt:P17
wd:Q30
p:P6153
wds:Q66031472-2A75F152-1578-4043-9C42-11639D9BE449
wdt:P6153
wd:Q7054727
p:P4844
wds:Q66031472-4A7D7DE1-47B2-4D83-BDB4-ABCD41A89C6E
wdt:P4844
wd:Q238512
p:P2899
wds:Q66031472-51CBFAF6-38B6-41E3-8A0B-4848C2B6711C
wdt:P2899
18
p:P1050
wds:Q66031472-5E0671E1-6CB3-412E-BC3E-172C001AC133
wdt:P1050
wd:Q356033
p:P1132
wds:Q66031472-A66234C4-CB2A-487B-9544-EA1C766EE0E4
wdt:P1132
50
p:P8363
wds:Q66031472-2416FB56-E9FC-4351-A96C-CA4F410722B3
wdt:P8363
wd:Q78089383
p:P3098
wds:Q66031472-D9C429A8-B617-4C83-98BB-22DA09B5AD58
wdt:P3098
NCT00096070
p:P6099
wds:Q66031472-00F350B7-E386-4918-94A1-45C7F9C9803C
wdt:P6099
wd:Q42824440